Professor Kwun Fong
Lung cancer is the biggest cause of cancer deaths in the world, with a huge burden of disease and very poor survival. As a researcher and clinician-scientist, Professor Kwun Fong’s vision is to improve health outcomes for patients with lung cancer and support their families by developing novel high value interventions, then implementing these into clinical practice. His full-time clinical role as a thoracic physician allows him to interact with people with lung cancer.
His early work after completion of his PhD in Brisbane led to highly-cited publications including a 2005 paper in the Journal of the National Cancer Institute on epidermal growth factor receptor gene mutations in lung cancer, which has been cited 1,464 times. His leadership in providing samples from patients with lung cancer, who have consented to be part of The Prince Charles Hospital Lung Bank in the Metro North HHS, led to contribution to a high impact publication in the leading scientific journal, Nature, with The Cancer Genome Atlas Research Network.
His track record has been exceptionally productive, with >$20 million awarded in 106 grants, 168 publications, and supervision of >40 HDR students. A multicentre study to test CT screening for lung cancer in 4,000 participants in Australia and Canada. This landmark prospective study will prospectively measure the effectiveness of lung cancer CT screening in Australia.
Kwun is the President of the Asian-Pacific Society of Respirology.